Galena receives notice of allowance of NeuVax patent

The USPTO issues a notice of allowance to Galena BioPharma (GALE) of a patent covering the use of NeuVax alone or in combination to prevent recurrence of any HER2/neu-expressing tumor having a fluorescence in situ hybridization ((FISH)) rating of less than ~2.0. The patent, once issued, will expire in 2028.

NeuVax is a peptide immunotherapy for the prevention of cancer recurrence. It is Galena's lead product.  Currently, there are no approved HER2-directed therapies for patients with FISH ratings < 2.0.

GALE shares are up 11% premarket on higher volume.

From other sites
Comments (7)
  • Budavar
    , contributor
    Comments (1405) | Send Message
    Is this our second chance?
    was my first reaction as a long time holder of GALE securities.


    All GALE observers know; the company got embroiled in a fiasco unrelated to its main business.
    This I offer as no excuse = but such hiccups routinely occur with start-ups often naively unfamiliar with the pitfalls lurking in arenas outside their focus, namely science. That is the case with at least one other pharma start up in my home town in Florida.


    May this notice of allowance of a patent relating to our main product open a new chapter in GALE's history, hopefully to the benefit of our brothers + sisters who are suffering pains unimaginable to the rest of us.
    1 Jul 2014, 09:20 AM Reply Like
  • deercreekvols
    , contributor
    Comments (9527) | Send Message
    Like a Phoenix, (GALE) is rising from the ashes...hoping no more hit pieces come out to harm this company...


    Second time is the charm.
    1 Jul 2014, 10:26 AM Reply Like
  • MichaelJ8
    , contributor
    Comments (869) | Send Message
    deercreekvols... you know as soon as gale breaks 4... you will see the hit pieces... like clock work
    1 Jul 2014, 01:57 PM Reply Like
  • deercreekvols
    , contributor
    Comments (9527) | Send Message
    already planning on the systematic dragging down of (GALE)...the yo-yo continues


    small speculative play...nothing ventured, nothing gained
    1 Jul 2014, 02:36 PM Reply Like
  • MichaelJ8
    , contributor
    Comments (869) | Send Message
    yes I am planning on the systematic dragging down of GALE, you know it will happen.


    I am just preparing myself to trade around it.
    1 Jul 2014, 05:59 PM Reply Like
  • Vigen
    , contributor
    Comments (94) | Send Message
    There we go again the pump and dump be careful
    1 Jul 2014, 08:50 PM Reply Like
  • Liupapa
    , contributor
    Comments (45) | Send Message
    May not dump again if the cloud of SEC investigation and law suit removed the bear will have no excuses.
    1 Jul 2014, 10:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs